Evidence map›Paper›PMID 41242993›Full record

ArticleInternational journal of colorectal disease2025

Machine learning-based prediction model for omental metastasis in right-sided colon cancer patients: a retrospective multicenter study.

Hao Zhang, Songtao Yu, Jun Xiang, Federico Maria Mongardini, Ludovico Docimo, Zekai Huang, Gang Wang, Yuliuming Wang, Yunxiao Liu, Chunlin Wang and 4 more

Abstract readMulticenter Study
In one paragraph

Article in International journal of colorectal disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Hao Zhang *Department of Colorectal Cancer Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
Songtao Yu *Department of Colorectal Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Jun Xiang *Department of Colorectal Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Federico Maria MongardiniDivision of General, Oncological, Mini-invasive and Obesity Surgery, University of Study of Campania "Luigi Vanvitelli", Naples, Italy.
Ludovico DocimoDivision of General, Oncological, Mini-invasive and Obesity Surgery, University of Study of Campania "Luigi Vanvitelli", Naples, Italy.
Zekai HuangDepartment of Colorectal Cancer Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
Gang WangDepartment of Colorectal Cancer Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
Yuliuming WangDepartment of Colorectal Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Yunxiao LiuDepartment of Colorectal Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Chunlin WangDepartment of Colorectal Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Weiyuan ZhangDepartment of Colorectal Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Yuping ZhuDepartment of Colorectal Cancer Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China. zhuyp@zjcc.org.cn.
Guiyu WangDepartment of Colorectal Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin, China. guiywang@163.com.
Meng WangDepartment of Colorectal Cancer Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China. wangmengzhimeng@163.com.

Funding

Huadong Medicine Joint Funds of the Zhejiang Provincial Natural Science Foundation of China LHDMY24H070002National Natural Science Foundation of China 82002506National Natural Science Foundation of China U23A20482Noncommunicable Chronic Diseases-National Science and Technology Major Project 2024ZD0520305Zhejiang Provincial Medical and Health Science and Technology Plan 2023RC135Zhejiang TCM science and technology plan 2024ZL303
6 · The paper itself

Abstract

purposeCurrent diagnostic modalities lack sufficient sensitivity for detecting omental metastasis (OM), often underestimating metastatic burden. Unlike traditional statistical model, machine learning (ML) model is designed to detect subtle variable interactions and model nonlinear patterns that traditional statistics overlook, enhancing the reliability of OM risk evaluation in clinical practice. The aim of the study was to build a ML model in preoperatively predicting OM in right-sided colon cancer (RCC) patients using a multicenter dataset.

methodsThis retrospective multicenter study included 1798 RCC patients: 1206 from Zhejiang Cancer Hospital (training set n = 804, test set n = 402) and 592 from the Second Affiliated Hospital of Harbin Medical University (validation set). OM status, tumor location, preoperative CEA level, preoperative CA199 level, Grade, histology, tumor size and age of patients were recorded. Six ML models including extreme gradient boosting (XGB), artificial neural network (ANN), logistic regression (LR), random forest (RF), support vector machine (SVM) and decision tree (DT) were developed for the OM prediction in RCC. The area under the receiver operator characteristic (ROC) curve (AUC), accuracy, sensitivity, specificity, precision, F1 score and decision curve analysis (DCA) were analyzed for judging predictive performance.

resultsThe OM rates in training set, test set and validation set were 10.4%, 9.5% and 10.0%, respectively. The XGB model outperforming five other algorithms (ANN, RF, LR, SVM, and DT) across training set (AUC = 0.924, 0.096 gain vs LR), internal test (AUC = 0.868, 0.038 gain vs LR) and validation set (AUC = 0.766, 0.065 gain vs LR). The comparison of accuracy, sensitivity, specificity, precision and F1 score revealed the XGB model exhibited the best performance. The DCA curve also suggested that XGB had better clinical decision-making capability than the other five models. Feature importance analysis highlighted preoperative CEA level and tumor location as key predictors.

conclusionOur study developed and validated an XGB-based machine learning model that could accurately predict OM in RCC patients using routine preoperative variables. This model demonstrates strong discriminative ability and clinical utility, assisting personalized risk stratification and appropriate treatment decisions.

Indexed as

Colonic NeoplasmsMachine LearningOmentumPeritoneal NeoplasmsAgedArea Under CurveFemaleHumansMaleMiddle AgedNeoplasm MetastasisNeural Networks, ComputerReproducibility of ResultsRetrospective StudiesROC CurveSupport Vector MachineMachine learningOmental metastasisRight-sided colon cancerRisk model

Identifiers

PMID41242993
PMCPMC12620311

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.